Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1981 May;44(2):396–404.

In vitro studies of enhanced IgG synthesis in severe alcoholic liver disease.

J R Wands, J L Dienstag, J R Weake, R S Koff
PMCID: PMC1537356  PMID: 6458431

Abstract

Elevated serum immunoglobulin levels are a frequent finding in patients with severe alcoholic liver disease. We measured in vitro peripheral blood lymphocyte IgA synthesis by radioimmunoassay in 13 patients with severe alcoholic liver disease and hypergammaglobulinaemia and in normal control subjects. We found an increase in spontaneous IgA synthesis compared to controls (P greater than 0.001). On the other hand, there was no difference between groups in percentage stimulation of IgG production by B cells exposed to pokeweed mitogen. We also searched for defects in concanavalin A (Con A) induced suppressor T cell activity. There was no difference between patients with alcoholic liver disease and controls in the capability of such suppressor T cells to inhibit the response of allogeneic cells to a T cell mitogen. Similarly, we examined the capability of Con A-induced suppressor T cells to inhibit pokeweed mitogen-stimulated IgG synthesis by both autologous and allogeneic responder cells and observed no difference between alcoholic patients and controls. Thus these measured suppressor T-T and T-B cell interactions appeared no different from those in control subjects. Our studies suggest, therefore, that B cell IgG synthesis in vitro is enhanced in alcoholic liver disease. Furthermore, the capability to induce suppressor T cells which affects both T and B cell function appears intact; a finding in contrast to our previous observation in chronic active hepatitis. The investigations suggest that enhanced spontaneous IgG synthesis in vitro may result from intense antigenic stimulation in vivo.

Full text

PDF
396

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bailey R. J., Krasner N., Eddleston A. L., Williams R., Tee D. E., Doniach D., Kennedy L. A., Batchelor J. R. Histocompatibility antigens, autoantibodies, and immunoglobulins in alcoholic liver disease. Br Med J. 1976 Sep 25;2(6038):727–729. doi: 10.1136/bmj.2.6038.727. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barona E., Pirola R. C., Leiber C. S. Small intestinal damage and changes in cell population produced by ethanol ingestion in the rat. Gastroenterology. 1974 Feb;66(2):226–234. [PubMed] [Google Scholar]
  3. Gleich G. J., Averbeck A. K., Swedlund H. A. Measurement of IgE in normal and allergic serum by radioimmunoassay. J Lab Clin Med. 1971 Apr;77(4):690–698. [PubMed] [Google Scholar]
  4. HAVENS W. P., Jr, MYERSON R. M., KLATCHKO J. Production of tetanus antitoxin by patients with hepatic cirrhosis. N Engl J Med. 1957 Oct 3;257(14):637–643. doi: 10.1056/NEJM195710032571402. [DOI] [PubMed] [Google Scholar]
  5. HUNTER W. M., GREENWOOD F. C. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature. 1962 May 5;194:495–496. doi: 10.1038/194495a0. [DOI] [PubMed] [Google Scholar]
  6. Hallgren H. M., Yunis E. J. Suppressor lymphocytes in young and aged humans. J Immunol. 1977 Jun;118(6):2004–2008. [PubMed] [Google Scholar]
  7. Hauptman S., Tomasi T. B., Jr Antibodies to human albumin in cirrhotic sera. J Clin Invest. 1974 Jul;54(1):122–127. doi: 10.1172/JCI107733. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hodgson H. J., Wands J. R., Isselbacher K. J. Alteration in suppressor cell activity in chronic active hepatitis. Proc Natl Acad Sci U S A. 1978 Mar;75(3):1549–1553. doi: 10.1073/pnas.75.3.1549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Penner E., Albini B., Milgrom F. Detection of circulating immune complexes in alcoholic liver disease. Clin Exp Immunol. 1978 Oct;34(1):28–31. [PMC free article] [PubMed] [Google Scholar]
  10. Protell R. L., Soloway R. D., Martin W. J., Schoenfield L. J., Summerskill W. H. Anti-Salmonella agglutinins in chronic active liver disease. Lancet. 1971 Aug 14;2(7720):330–332. doi: 10.1016/s0140-6736(71)90056-0. [DOI] [PubMed] [Google Scholar]
  11. Rodbard D. Statistical quality control and routine data processing for radioimmunoassays and immunoradiometric assays. Clin Chem. 1974 Oct;20(10):1255–1270. [PubMed] [Google Scholar]
  12. Sakane T., Green I. Human suppressor T cells induced by concanavalin A: suppressor T cells belong to distinctive T cell subclasses. J Immunol. 1977 Sep;119(3):1169–1178. [PubMed] [Google Scholar]
  13. Schwartz S. A., Shou L., Good R. A., Choi Y. S. Suppression of immunoglobulin synthesis and secretion by peripheral blood lymphocytes from normal donors. Proc Natl Acad Sci U S A. 1977 May;74(5):2099–2103. doi: 10.1073/pnas.74.5.2099. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Shou L., Schwartz S. A., Good R. A. Suppressor cell activity after concanavalin A treatment of lymphocytes from normal donors. J Exp Med. 1976 May 1;143(5):1100–1110. doi: 10.1084/jem.143.5.1100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Thomas H. C., Potter B. J., Sherlock S. Is primary biliary cirrhosis an immune complex disease? Lancet. 1977 Dec 17;2(8051):1261–1263. doi: 10.1016/s0140-6736(77)92666-6. [DOI] [PubMed] [Google Scholar]
  16. Thompson R. A., Carter R., Stokes R. P., Geddes A. M., Goodall J. A. Serum immunoglobulins, complement component levels and autoantibodies in liver disease. Clin Exp Immunol. 1973 Jul;14(3):335–346. [PMC free article] [PubMed] [Google Scholar]
  17. Triger D. R., Alp M. H., Wright R. Bacterial and dietary antibodies in liver disease. Lancet. 1972 Jan 8;1(7741):60–63. doi: 10.1016/s0140-6736(72)90061-x. [DOI] [PubMed] [Google Scholar]
  18. Triger D. R., MacCallum F. O., Kurtz J. B., Wright R. Raised antibody titres to measles and rubella viruses in chronic active hepatitis. Lancet. 1972 Mar 25;1(7752):665–667. doi: 10.1016/s0140-6736(72)90465-5. [DOI] [PubMed] [Google Scholar]
  19. Triger D. R. Some immunological aspects of liver function. Yale J Biol Med. 1975 Mar;48(1):47–54. [PMC free article] [PubMed] [Google Scholar]
  20. Triger D. R., Wright R. Hyperglobulinaemia in liver disease. Lancet. 1973 Jun 30;1(7818):1494–1496. doi: 10.1016/s0140-6736(73)91827-8. [DOI] [PubMed] [Google Scholar]
  21. Triger D. R., Wright R. Hyperglobulinaemia in liver disease. Lancet. 1973 Jun 30;1(7818):1494–1496. doi: 10.1016/s0140-6736(73)91827-8. [DOI] [PubMed] [Google Scholar]
  22. Wands J. R., Alpert E., Isselbacher K. J. Arthritis associated with chronic active hepatitis: complement activation and characterization of circulating immune complexes. Gastroenterology. 1975 Dec;69(6):1286–1291. [PubMed] [Google Scholar]
  23. Wands J. R., Dienstag J. L., Bhan A. K., Feller E. R., Isselbacher K. J. Circulating immune complexes and complement activation in primary biliary cirrhosis. N Engl J Med. 1978 Feb 2;298(5):233–237. doi: 10.1056/NEJM197802022980502. [DOI] [PubMed] [Google Scholar]
  24. Worthington B. S., Meserole L., Syrotuck J. A. Effect of daily ethanol ingestion on intestinal permeability to macromolecules. Am J Dig Dis. 1978 Jan;23(1):23–32. doi: 10.1007/BF01072571. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES